rs775014444

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS3PM2PP3_ModeratePP5_Very_Strong

The NM_005993.5(TBCD):​c.1423G>A​(p.Ala475Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000329619: Published functional studies demonstrate a damaging effect with reduction of protein expression in patient fibroblasts (PMID:28158450)" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. A475A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000096 ( 0 hom. )

Consequence

TBCD
NM_005993.5 missense

Scores

11
7

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 7.26

Publications

7 publications found
Variant links:
Genes affected
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
TBCD Gene-Disease associations (from GenCC):
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000329619: Published functional studies demonstrate a damaging effect with reduction of protein expression in patient fibroblasts (PMID: 28158450); SCV004176410: Experimental studes have shown that this missense change alters TBCD gene expression (Pode-Shakked B,et al., 2017).; SCV005077171: The variant allele was found at a frequency of 1.2e-05 in 248244 control chromosomes (gnomAD). c.1423G>A has been reported in the literature in multiple individuals affected with infantile neurodegenerative disorders including Encephalopathy, Early Onset (e.g. Edvardson_2016, AlAbdi_2023). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding ~10% of normal TBCD intracellular abundance in fibroblasts from homozygous patient fibroblasts (Edvardson_2016). PMID: 28158450 "~10% of normal TBCD intracellular abundance in fibroblasts from homozygous patient fibroblasts (Edvardson_2016)." PMID: 28158450
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.897
PP5
Variant 17-82870328-G-A is Pathogenic according to our data. Variant chr17-82870328-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 279953.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005993.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
NM_005993.5
MANE Select
c.1423G>Ap.Ala475Thr
missense
Exon 14 of 39NP_005984.3
TBCD
NM_001411101.1
c.1372G>Ap.Ala458Thr
missense
Exon 13 of 38NP_001398030.1A0A804HLI2
TBCD
NM_001411102.1
c.1423G>Ap.Ala475Thr
missense
Exon 14 of 38NP_001398031.1A0A804HJ32

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
ENST00000355528.9
TSL:1 MANE Select
c.1423G>Ap.Ala475Thr
missense
Exon 14 of 39ENSP00000347719.4Q9BTW9-1
TBCD
ENST00000684760.1
c.1423G>Ap.Ala475Thr
missense
Exon 14 of 40ENSP00000507696.1A0A804HJY5
TBCD
ENST00000684349.1
c.1423G>Ap.Ala475Thr
missense
Exon 14 of 39ENSP00000508067.1A0A804HKT8

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000121
AC:
3
AN:
248244
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000178
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.00000958
AC:
14
AN:
1461130
Hom.:
0
Cov.:
37
AF XY:
0.00000825
AC XY:
6
AN XY:
726860
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52896
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000809
AC:
9
AN:
1111838
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.000111
Hom.:
0
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
7
-
-
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome (7)
2
-
-
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.20
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.51
D
Eigen
Pathogenic
0.88
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.31
D
MetaRNN
Pathogenic
0.90
D
MetaSVM
Uncertain
0.58
D
MutationAssessor
Pathogenic
3.7
H
PhyloP100
7.3
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-3.7
D
REVEL
Pathogenic
0.67
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.86
MutPred
0.60
Gain of phosphorylation at A475 (P = 0.2524)
MVP
0.82
MPC
0.93
ClinPred
0.99
D
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.51
gMVP
0.70
Mutation Taster
=12/88
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs775014444; hg19: chr17-80828204; COSMIC: COSV62804420; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.